首页> 外国专利> RETINOIC ACID RECEPTOR BETA-2 AND GENE THERAPY VECTORS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS

RETINOIC ACID RECEPTOR BETA-2 AND GENE THERAPY VECTORS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS

机译：维甲酸受体β2和基因治疗载体治疗神经性疾病

页面导航

摘要

The present invention relates to the use of RAR beta 2 and/or an agonist thereof in the preparation of a medicament to cause neurite development.

机译：本发明涉及RARβ2和/或其激动剂在制备引起神经突发展的药物中的用途。

公开/公告号EP1268835B1

专利类型
公开/公告日2008-01-16

原文格式PDF
申请/专利权人 OXFORD BIOMEDICA (UK) LIMITED;
展开▼

申请/专利号EP20010917270
发明设计人 KINGSMAN ALAN JOHNOXFORD BIOMEDICA (UK) LTD;MADEN MBIOMEDICAL SCIENCES DIVISION;CORCORAN JBIOMEDICAL SCIENCES DIVISION;
展开▼

申请日2001-03-30
分类号C12N15/867;C12N15/12;C07K14/705;G01N33/68;A61K38/17;A61K31/203;A61K31/381;A61K48;A61P25;
国家 EP
入库时间 2022-08-21 19:59:34